Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$1.23K 11209
2025
Q3
$1.23K Hold
1
﹤0.01% 9401
2025
Q2
$4.29K Sell
1
-11
-92% -$37.2K ﹤0.01% 9284
2025
Q1
$36.6K Buy
+12
New +$44.6K ﹤0.01% 7816
2024
Q4
Sell
-2
Closed -$11.8K 9834
2024
Q3
$10.2K Buy
+2
New +$16.2K ﹤0.01% 7738
2024
Q2
Hold
0
9376
2024
Q1
Hold
0
9167
2023
Q4
Hold
0
9169
2023
Q3
Sell
-1
Closed -$4.46K 9304
2023
Q2
$2.42K Hold
1
﹤0.01% 7754
2023
Q1
$6.45K Buy
+1
New +$4.66K ﹤0.01% 7917
2022
Q4
Sell
-1
Closed -$4.58K 10621
2022
Q3
$3K Hold
1
﹤0.01% 9593
2022
Q2
$8K Hold
1
﹤0.01% 8357
2022
Q1
$12K Buy
+1
New +$10.7K ﹤0.01% 8203

Other funds holding VIVK

UBS Group's VIVK Position: Q4 2025 in Review

UBS Group sold out of Vivakor (VIVK) in Q4 2025, closing a stake of 1 share — an estimated $1.23K sold.

UBS Group first reported a position in VIVK in Q1 2022 and held it in 9 quarters. The position peaked at $36.6K in Q1 2025. 4 funds tracked by Wall St. Rank hold VIVK as of Q4 2025.

  • UBS Group reported no remaining Vivakor position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 1 Vivakor share in Q4 2025, an estimated $1.23K.
  • UBS Group first reported a position in Vivakor in Q1 2022 and held it in 9 quarters.
  • UBS Group's Vivakor position peaked at $36.6K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Vivakor as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.